International Patent: CD5-TARGETED LIPID NANOPARTICLES ENCAPSULATING POLYRIBONUCLEOTIDES ENCODING CHIMERIC ANTIGEN RECEPTORS, AND METHODS TO GENERATE CAR-EXPRESSING T CELLS IN VIVO

GENEVA, July 18 -- SAIL BIOMEDICINES, INC. filed a patent application (US2026/011169) for “CD5-TARGETED LIPID NANOPARTICLES ENCAPSULATING POLYRIBONUCLEOTIDES ENCODING CHIMERIC ANTIGEN RECEPTORS, AND METHODS TO GENERATE CAR-EXPRESSING T CELLS IN VIVO”. With publication no. WO/2026/152164, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 40/11

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....